4D Paths Physics-Inspired QPOR Platform Predicts Neoadjuvant Chemotherapy Response from Routine Biopsy Images in Early-Stage Triple-Negative Breast Cancer from Phase II TBCRC-030 Trial
NEWTON, Mass., Dec. 03, 2025 (GLOBE NEWSWIRE) -- 4D Path, a company…
AMPS Achieves HITRUST e1 Certification, Solidifying Commitment to Data Security in Healthcare
PHOENIX, Dec. 02, 2025 (GLOBE NEWSWIRE) -- AMPS, a healthcare technology solutions…
Cosmos Health CEO Greg Siokas Adds 3,398,055 Shares Year-to-Date 2025 Following Continued November Purchases
CHICAGO, Dec. 02, 2025 (GLOBE NEWSWIRE) -- Cosmos Health Inc. ("Cosmos Health"…
Quetzal Therapeutics Launches Phase III Clinical Trial of Oral QTX-2101 for Acute Promyelocytic Leukemia (APL)
CHICAGO, Dec. 02, 2025 (GLOBE NEWSWIRE) -- Quetzal Therapeutics, a biopharmaceutical company…
COSCIENS Announces Exclusive Distribution Agreement with Wuzhou Drug International for Macrilen in Hainan-Guangdong-Hong Kong-Macao Greater Bay Area and Singapore
TORONTO, ONTARIO, Dec. 01, 2025 (GLOBE NEWSWIRE) -- COSCIENS Biopharma Inc. (TSX:…
Integra LifeSciences Leadership to Present at the Citi 2025 Global Healthcare Conference
PRINCETON, N.J., Dec. 01, 2025 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation…
Receipt of Delinquency Notification from Nasdaq
Singapore, Dec. 01, 2025 (GLOBE NEWSWIRE) -- Basel Medical Group Ltd (Nasdaq:…
Philips launches Verida, worlds first detector-based spectral CT powered by breakthrough AI, to advance diagnostic precision
November 30, 2025 Philips pioneered detector-based spectral CT, which has been widely…
Philips unveils BlueSeal Horizon, industrys first helium-free 3.0T MRI platform
November 30, 2025 Major technology breakthrough combines advanced AI for clinical insights…
